Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Current Assets (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Current Assets for 16 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 14.53% to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.4 million, a 14.53% decrease, with the full-year FY2024 number at $6.1 million, down 40.27% from a year prior.
  • Current Assets was $5.4 million for Q3 2025 at Creative Medical Technology Holdings, down from $6.6 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $22.9 million in Q2 2022 to a low of $158588.0 in Q2 2021.
  • A 5-year average of $9.8 million and a median of $9.2 million in 2024 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: skyrocketed 14370.99% in 2022, then plummeted 47.43% in 2024.
  • Creative Medical Technology Holdings' Current Assets stood at $10.7 million in 2021, then surged by 74.6% to $18.7 million in 2022, then crashed by 45.21% to $10.3 million in 2023, then plummeted by 40.27% to $6.1 million in 2024, then decreased by 11.8% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Current Assets are $5.4 million (Q3 2025), $6.6 million (Q2 2025), and $7.8 million (Q1 2025).